Functional Toll-Like Receptor (TLR)2 polymorphisms in the susceptibility to inflammatory bowel disease. by Helga Paula Török, Victor Bellon, Astrid Konrad, Martin Lacher, Laurian Tonenchi, Matthias Siebeck, Stephan Brand, Enrico Narciso De Toni

Get full text

Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial by Max Seidensticker, Osman Öcal, Kerstin Schütte, Peter Malfertheiner, Thomas Berg, Christian Loewe, Heinz Josef Klümpen, Otto van Delden, Muzaffer Reha Ümütlü, Najib Ben Khaled, Enrico Narciso de Toni, Ricarda Seidensticker, Ali Aghdassi, Albert Tran, Jean-Pierre Bronowicki, Bora Peynircioglu, Bruno Sangro, Maciej Pech, Jens Ricke

Get full text